DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia.

MLA

Patnaik, Mrinal M., et al. “DNMT3A Mutations Are Associated with Inferior Overall and Leukemia-Free Survival in Chronic Myelomonocytic Leukemia.” American Journal of Hematology, vol. 92, no. 1, Jan. 2017, pp. 56–61. EBSCOhost, https://doi.org/10.1002/ajh.24581.

APA

Patnaik, M. M., Barraco, D., Lasho, T. L., Finke, C. M., Hanson, C. A., Ketterling, R. P., Gangat, N., & Tefferi, A. (2017). DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia. American Journal of Hematology, 92(1), 56–61. https://doi.org/10.1002/ajh.24581

Chicago

Patnaik, Mrinal M, Daniela Barraco, Terra L Lasho, Christy M Finke, Curtis A Hanson, Rhett P Ketterling, Naseema Gangat, and Ayalew Tefferi. 2017. “DNMT3A Mutations Are Associated with Inferior Overall and Leukemia-Free Survival in Chronic Myelomonocytic Leukemia.” American Journal of Hematology 92 (1): 56–61. doi:10.1002/ajh.24581.